Portal vein thrombosis is a risk factor for poor early outcomes after liver transplantation: Analysis of risk factors and outcomes for portal vein thrombosis in waitlisted patients

Transplantation

Volumn 100, Issue 1, 2016, Pages 126-133

  Ghabril, Marwan ^a   Agarwal, Saurabh ^a   Lacerda, Marco ^a   Chalasani, Naga ^a   Kwo, Paul ^a   Joseph Tector, A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; ASCITES; CONTROLLED STUDY; DIABETES MELLITUS; FATTY LIVER; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEPATITIS C; HUMAN; LIVER CANCER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; OBESITY; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; COMPLICATION; HOSPITAL ADMISSION; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; PROPENSITY SCORE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TRANSPLANTATION; TREATMENT OUTCOME; VENOUS THROMBOSIS;

CHI-SQUARE DISTRIBUTION; FEMALE; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; PROPENSITY SCORE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; VENOUS THROMBOSIS; WAITING LISTS;

EID: 84952331810     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000785     Document Type: Article

References (19)

1. Ponziani FR, Zocco MA, Garcovich M, et al.What we should know about portal vein thrombosis in cirrhotic patients: A changing perspective. World J Gastroenterol. 2012;18(36):5014-5020.
2. Tripodi A, Anstee QM, Sogaard KK, et al. Hypercoagulability in cirrhosis: causes and consequences. J Thromb Haemost. 2011;9(9):1713-1723.
3. Zocco MA, Di Stasio E, De Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol. 2009;51(4):682-689.
4. Amitrano L, Guardascione MA, Brancaccio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004;40(5):736-741.
5. Werner KT, Sando S, Carey EJ, et al. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. Dig Dis Sci. 2013;58(6):1776-1780.
6. Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol. 2012;57(1):203-212.
7. Rodriguez-Castro KI, Porte RJ, Nadal E, et al. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: A systematic review. Transplantation. 2012;94(11):1145-1153.
8. Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation. 2000;69(9):1873-1881.
9. Lendoire J, Raffin G, Cejas N, et al. Liver transplantation in adult patients with portal vein thrombosis: risk factors, management and outcome. HPB (Oxford). 2007;9(5):352-356.
10. John BV, Konjeti R, Aggarwal A, et al. Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis. Ann Hepatol. 2013;12(6):952-958.
11. Levi Sandri GB, Lai Q, Berloco PB, et al. Portal vein thrombosis before liver transplant does not alter postoperative patient or graft survival. Exp Clin Transplant. 2014;12(3):238-240.
12. Hibi T, Nishida S, Levi DM, et al. When and why portal vein thrombosis matters in liver transplantation: A critical audit of 174 cases. Ann Surg. 2014;259(4):760-766.
13. Englesbe MJ, Schaubel DE, Cai S, et al. Portal vein thrombosis and liver transplant survival benefit. Liver Transpl. 2010;16(8):999-1005.
14. Molmenti EP, Roodhouse TW, Molmenti H, et al. Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg. 2002;235(2):292-296.
15. Nikitin D, Jennings LW, Khan T, et al. Twenty years follow-up of portal vein conduits in liver transplantation. Liver Transpl. 2009;15(4):400-406.
16. Manzanet G, Sanjuan F, Orbis P, et al. Liver transplantation in patients with portal vein thrombosis. Liver Transpl. 2001;7(2):125-131.
17. Northup PG, Argo CK, Shah N, et al. Hypercoagulation and thrombophilia in nonalcoholic fatty liver disease: mechanisms, human evidence, therapeutic implications, and preventive implications. Semin Liver Dis. 2012;32(1):39-48.
18. Assy N, Bekirov I, Mejritsky Y, et al. Association between thrombotic risk factors and extent of fibrosis in patients with non-Alcoholic fatty liver diseases. World J Gastroenterol. 2005;11(37):5834-5839.
19. Ayala R, Grande S, Bustelos R, et al. Obesity is an independent risk factor for pre-Transplant portal vein thrombosis in liver recipients. BMC Gastroenterol. 2012;12:114.